However, it is well known that APP-altered metabolism in AD is responsible for the higher liberation of amyloid β, which may play a crucial role in the pathogenesis/pathomechanism of the familiar/genetic form of early-onset AD (EOAD). Here, APP is linked to Alzheimer disease.